SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-045744
Filing Date
2019-12-11
Accepted
2019-12-11 16:18:59
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-10q_20190930.htm 10-Q 2611093
2 EX-31.1 rapt-ex311_7.htm EX-31.1 16555
3 EX-31.2 rapt-ex312_6.htm EX-31.2 16522
4 EX-32.1 rapt-ex321_8.htm EX-32.1 14711
  Complete submission text file 0001564590-19-045744.txt   6767642

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rapt-20190930.xml EX-101.INS 1314015
6 XBRL TAXONOMY EXTENSION SCHEMA rapt-20190930.xsd EX-101.SCH 43763
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rapt-20190930_cal.xml EX-101.CAL 28943
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rapt-20190930_def.xml EX-101.DEF 152619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20190930_lab.xml EX-101.LAB 319667
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20190930_pre.xml EX-101.PRE 255041
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 191280000
SIC: 2834 Pharmaceutical Preparations